Literature DB >> 16819582

The future of cardiovascular imaging and non-invasive diagnosis. A joint statement from the European Association of Echocardiography, the Working Groups on Cardiovascular Magnetic Resonance, Computers in Cardiology, and Nuclear Cardiology, of the European Society of Cardiology, the European Association of Nuclear Medicine and the Association for European Paediatric Cardiology.

Alan G Fraser1, Peter T Buser, Jeroen J Bax, Willem R Dassen, Petros Nihoyannopoulos, Jürg Schwitter, Juhani M Knuuti, Martin Höher, Frank Bengel, András Szatmári.   

Abstract

Advances in medical imaging now make it possible to investigate any patient with cardiovascular disease using multiple methods which vary widely in their technical requirements, benefits, limitations and costs. The appropriate use of alternative tests requires their integration into joint clinical diagnostic services where experts in all methods collaborate. This statement summarises the principles that should guide developments in cardiovascular diagnostic services.

Entities:  

Mesh:

Year:  2006        PMID: 16819582     DOI: 10.1007/s00259-006-0201-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  2 in total

Review 1.  American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from?

Authors:  Raymond J Gibbons; Sidney Smith; Elliott Antman
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

2.  Report on the first written exam held as part of the European Association of Echocardiography accreditation process in adult transthoracic echocardiography.

Authors:  Kevin F Fox; Frank Flachskampf; Jose Luis Zamorano; Luigi Badano; Alan G Fraser; Fausto J Pinto
Journal:  Eur J Echocardiogr       Date:  2004-10
  2 in total
  1 in total

Review 1.  Myocardial perfusion imaging by cardiac magnetic resonance.

Authors:  Juerg Schwitter
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.